Search research articles
Contact Us
Filters
Showing results (181-190 of 258) with videos related to
Page
of 26
Sort By:
The British Journal of Dermatology
|
February 3, 2024
Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial
Eva Grekowitz, Martin Metz, Sabine Altrichter, et al.
Allergy
|
August 26, 2021
Automatic screening of self-evaluation apps for urticaria and angioedema shows a high unmet need
Aram Antó, Rasmus Maurer, Ana Gimenez-Arnau, et al.
Nature
|
November 16, 2004
Mast cells promote homeostasis by limiting endothelin-1-induced toxicity
Marcus Maurer, Jochen Wedemeyer, Martin Metz, et al.
The Journal of Allergy and Clinical Immunology. Global
|
March 19, 2026
Dupilumab in patients with cold urticaria: Results from a phase 3 trial
Martin Metz, Sarbjit S Saini, Akiko Yagami, et al.
Frontiers in Immunology
|
November 29, 2023
In the skin lesions of patients with mycosis fungoides, the number of MRGPRX2-expressing cells is increased and correlates with mast cell numbers
Man Hu, Polina Pyatilova, Sabine Altrichter, et al.
Allergy
|
August 5, 2018
Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab
Karsten Weller, Tatevik Ohanyan, Tomasz Hawro, et al.
Journal of the American Academy of Dermatology
|
August 21, 2025
Safety and efficacy of barzolvolimab, an anti-KIT monoclonal antibody, in adults with moderate-to-severe prurigo nodularis: A randomized phase 1b intravenous single-dose study
Martin Metz, Sonja Ständer, Ali Moiin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 29, 2025
Depletion of mast cells with barzolvolimab, an anti-KIT antibody, does not affect mast cell progenitors
Sherezade Moñino-Romero, Niklas Amadeus Mahnke, Dorothea Terhorst-Molawi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 28, 2026
Differential susceptibility of hair colour changes after barzolvolimab
Melba Muñoz, Jimmy Zhou, Hanna Bonnekoh, et al.
Journal of the American Academy of Dermatology
|
June 6, 2025
Human papillomavirus infection increases risk of new-onset prurigo nodularis: A multicenter retrospective cohort study using global and US electronic medical records of TriNetX network
Shuo-Yan Gau, Shao-Wei Lo, Yung-Fang Tu, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 258) with videos related to
Sort By:
Page
of 26
The British Journal of Dermatology
|
February 3, 2024
Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial
Eva Grekowitz, Martin Metz, Sabine Altrichter, et al.
Allergy
|
August 26, 2021
Automatic screening of self-evaluation apps for urticaria and angioedema shows a high unmet need
Aram Antó, Rasmus Maurer, Ana Gimenez-Arnau, et al.
Nature
|
November 16, 2004
Mast cells promote homeostasis by limiting endothelin-1-induced toxicity
Marcus Maurer, Jochen Wedemeyer, Martin Metz, et al.
The Journal of Allergy and Clinical Immunology. Global
|
March 19, 2026
Dupilumab in patients with cold urticaria: Results from a phase 3 trial
Martin Metz, Sarbjit S Saini, Akiko Yagami, et al.
Frontiers in Immunology
|
November 29, 2023
In the skin lesions of patients with mycosis fungoides, the number of MRGPRX2-expressing cells is increased and correlates with mast cell numbers
Man Hu, Polina Pyatilova, Sabine Altrichter, et al.
Allergy
|
August 5, 2018
Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab
Karsten Weller, Tatevik Ohanyan, Tomasz Hawro, et al.
Journal of the American Academy of Dermatology
|
August 21, 2025
Safety and efficacy of barzolvolimab, an anti-KIT monoclonal antibody, in adults with moderate-to-severe prurigo nodularis: A randomized phase 1b intravenous single-dose study
Martin Metz, Sonja Ständer, Ali Moiin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 29, 2025
Depletion of mast cells with barzolvolimab, an anti-KIT antibody, does not affect mast cell progenitors
Sherezade Moñino-Romero, Niklas Amadeus Mahnke, Dorothea Terhorst-Molawi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 28, 2026
Differential susceptibility of hair colour changes after barzolvolimab
Melba Muñoz, Jimmy Zhou, Hanna Bonnekoh, et al.
Journal of the American Academy of Dermatology
|
June 6, 2025
Human papillomavirus infection increases risk of new-onset prurigo nodularis: A multicenter retrospective cohort study using global and US electronic medical records of TriNetX network
Shuo-Yan Gau, Shao-Wei Lo, Yung-Fang Tu, et al.
Page
of 26